Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
CHAMPIONS ONCOLOGY, INC. (CSBR) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/24/2023 8-K Quarterly results
04/05/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Announces $5M Stock Repurchase Program"
03/15/2023 8-K Quarterly results
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Quarterly Revenue of $12.8 Million"
12/13/2022 8-K Quarterly results
10/20/2022 8-K Quarterly results
09/08/2022 8-K Quarterly results
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Record Quarterly Revenue of $13.7 Million"
07/21/2022 8-K Quarterly results
03/15/2022 8-K Quarterly results
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Record Quarterly Revenue of $13.2 Million Reported Adjusted EBITDA of $1.5 million"
12/13/2021 8-K Quarterly results
10/21/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
09/13/2021 8-K Quarterly results
07/22/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Champions Oncology Reports Quarterly Revenue of $10.6 Million Record Annual Revenue of $41 Million"
03/11/2021 8-K Quarterly results
02/12/2021 8-K Quarterly results
12/14/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "One University Plaza, Suite 307 Hackensack, NJ 07601 Tel: 551-206-8104 Champions Oncology Reports Record Quarterly Revenue of $10.1 Million"
10/21/2020 8-K Quarterly results
10/15/2020 8-K Quarterly results
09/14/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Champions Oncology Reports Record Quarterly Revenue of $9.5 Million"
07/27/2020 8-K Quarterly results
03/30/2020 8-K Quarterly results
03/12/2020 8-K Quarterly results
01/03/2020 8-K Quarterly results
12/16/2019 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Champions Oncology Reports Quarterly Revenue of $7.6 Million Records Second Quarter Income of $291,000 Hackensack, NJ – December 16, 2019 – Champions Oncology, Inc. , engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced its financial results for the second fiscal quarter ended October 31, 2019. Second Quarter and Recent Business Highlights:"
10/16/2019 8-K Submission of Matters to a Vote of Security Holders
09/16/2019 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Champions Oncology Reports Quarterly Revenue of $6.7 Million Hackensack, NJ – September 16, 2019 – Champions Oncology, Inc. , engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced its financial results for the first fiscal quarter ended July 31, 2019. First Quarter and Recent Business Highlights: • Quarterly revenue of $6.7 million, an increase of 8.2% year-over-year • Record quarterly bookings • Launched clinical flow services Ronnie Morris, CEO of Champions, commented, “While our first quarter financial results were slightly weaker than expected, the cause was mainly due to the timing of study completions and revenue recognition.” Morris added, “We began aggressively selling our r..."
09/05/2019 8-K Investor presentation
Docs: "Investor Relations Slideshow in use beginning September 5, 2019 (furnished only)"
07/15/2019 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended Record Annual Revenue of $27 Million"
03/18/2019 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Champions Oncology Reports Quarterly Revenue of $6.4 Million Reiterates Expectations for Revenue Growth of at Least 20% for Fiscal Year 2019 Hackensack, NJ – March 18, 2019 – Champions Oncology, Inc. , engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced its financial results for the third fiscal quarter ended January 31, 2019. Third Quarter and Recent Business Highlights:"
01/07/2019 8-K Investor presentation
Docs: "Investor presentation materials"
12/17/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Champions Oncology Reports Record Quarterly Revenue of $6.7 Million Reiterates Expectations for Revenue Growth of at Least 20% for Fiscal Year 2019"
10/16/2018 8-K Quarterly results
09/13/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Champions Oncology Reports Record Quarterly Revenue of $6.2 Million Reiterates Expectations for Revenue Growth of at Least 20% for Fiscal Year 2019"
07/26/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018 Expects Revenue Growth of at Least 20% for Fiscal Year 2019"
03/15/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Champions Oncology Reports Quarterly Revenue of $5.1 Million Company Generates Positive Cash Flow from Operations; Reiterates Expectations for Revenue Growth of at Least 20% for Fiscal Year 2018"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy